Eric Stephen Schafer MD
Assistant Professor of Pediatrics, Division of Pediatric Hematology and Oncology, Baylor College of Medicine, Houston, TX
Join to View Full Profile
6701 Fannin St.Suite 1400Houston, TX 77030
Phone+1 832-822-4242
Dr. Schafer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Clinical Pharmacology, 2012 - 2015
Johns Hopkins Bloomberg School of Public HealthMHS, Clinical Investigation, 2011 - 2012
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2006 - 2009
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2003 - 2006- Baylor College of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2012 - 2026
MD State Medical License 2006 - 2013
PA State Medical License 2003 - 2006
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK) Start of enrollment: 2013 Aug 28
- Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate Start of enrollment: 2014 Jan 01
- Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16
- Join now to see all
Publications & Presentations
PubMed
- Absorption of Oral Chemotherapy in a Pediatric Patient with T-Cell Acute Lymphoblastic Leukemia, Short Bowel Syndrome, and Skewed 6-Mercaptopurine Metabolism.Kevin M Nguyen, Bhamini Shekhawat, Eric S Schafer, Smita Bhaskaran
Pediatric Blood & Cancer. 2025-08-01 - Neuroleukemiosis Masquerading as Drug Toxicity in an Adolescent With Refractory AML.Nia Choi, Deborah Schady, Tim Lotze, Jill Ann Jarrell, Alexandra Rodriguez-Hernandez
American Journal of Hematology. 2025-07-23 - Daratumumab as a Toxicity-Sparing Agent During Frontline Treatment of T-Cell Acute Lymphoblastic Leukemia.Meghan Shekar, Linda Zhang, Hana Paek, Eric S Schafer, Shannon E Conneely
Pediatric Blood & Cancer. 2025-07-17
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
